SCHEMBL23578704

SCHEMBL23578704

CCn1c2nc(=O)[nH]c(=O)c-2nc2cc(C#N)c(C#N)cc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 6/20 0.49
▸ KMT2A Q03164 6/20 0.49
▸ USP2 O75604 4/20 0.49
▸ HTT P42858 4/20 0.49
▸ KDM4E B2RXH2 3/20 0.49
▸ MAPT P10636 3/20 0.49
▸ TDP1 Q9NUW8 2/20 0.49
▸ RXFP1 Q9HBX9 2/20 0.49
▸ IDO1 P14902 1/20 0.49
▸ HAT1 O14929 4/20 0.47
▸ RBBP7 Q16576 4/20 0.47
▸ RECQL P46063 3/20 0.47
▸ CASP7 P55210 3/20 0.47
▸ HSD17B10 Q99714 3/20 0.47
▸ CASP1 P29466 2/20 0.47
▸ BRCA1 P38398 2/20 0.47
▸ TST Q16762 2/20 0.47
▸ LMNA P02545 1/20 0.47
▸ HBB P68871 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23598610 0.91 KDM4E (0.53) MEN1KMT2AUSP2HTTKDM4E
SCHEMBL24636097 0.88 MEN1 (0.50) MEN1KMT2AUSP2HTTKDM4E
SCHEMBL23598611 0.86 MEN1 (0.50) MEN1KMT2AUSP2HTTKDM4E
SCHEMBL23598608 0.86 MEN1 (0.53) MEN1KMT2AUSP2HTTKDM4E
SCHEMBL23598553 0.85 KDM4E (0.44) MEN1KMT2AUSP2HTTKDM4E
SCHEMBL23598910 0.84 KMT2A (0.44) MEN1KMT2AUSP2HTTKDM4E
SCHEMBL24636077 0.84 MEN1 (0.48) MEN1KMT2AUSP2HTTKDM4E
SCHEMBL23598674 0.83 KDM4E (0.53) MEN1KMT2AUSP2HTTKDM4E
SCHEMBL23598569 0.82 MEN1 (0.49) MEN1KMT2AUSP2HTTKDM4E
SCHEMBL23598685 0.81 MEN1 (0.48) MEN1KMT2AUSP2HTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12617793-B2 Organic electron transfer mediator and device comprising same I-SENS, INC. (KR) 2026-05-05 — — US disclosed
US-20230102721-A1 NOVEL ORGANIC ELECTRON TRANSFER MEDIATOR AND DEVICE COMPRISING SAME I-SENS, INC. (KR) 2023-03-30 — — US disclosed
EP-4083043-A1 NOVEL ORGANIC ELECTRON TRANSFER MEDIATOR AND DEVICE COMPRISING SAME I-SENS, INC. (KR) 2022-11-02 — — EP disclosed
WO-2021133144-A1 NOVEL ORGANIC ELECTRON TRANSFER MEDIATOR AND DEVICE COMPRISING SAME 주식회사 아이센스 2021-07-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12617793-B2 Organic electron transfer mediator and device comprising same SCO2, ETFB, MT-CO1 MEN1 3398/4885KMT2A 2945/4885USP2 3494/4885
US-20230102721-A1 NOVEL ORGANIC ELECTRON TRANSFER MEDIATOR AND DEVICE COMPRISING SAME MT-ND4, MT-ND2, SLC25A21 MEN1 2832/4885KMT2A 2459/4885USP2 3802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback